Your browser doesn't support javascript.
loading
Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial.
Schubert, Maria-Luisa; Schmitt, Anita; Hückelhoven-Krauss, Angela; Neuber, Brigitte; Kunz, Alexander; Waldhoff, Philip; Vonficht, Dominik; Yousefian, Schayan; Jopp-Saile, Lea; Wang, Lei; Korell, Felix; Keib, Anna; Michels, Birgit; Haas, Dominik; Sauer, Tim; Derigs, Patrick; Kulozik, Andreas; Kunz, Joachim; Pavel, Petra; Laier, Sascha; Wuchter, Patrick; Schmier, Johann; Bug, Gesine; Lang, Fabian; Gökbuget, Nicola; Casper, Jochen; Görner, Martin; Finke, Jürgen; Neubauer, Andreas; Ringhoffer, Mark; Wolleschak, Denise; Brüggemann, Monika; Haas, Simon; Ho, Anthony D; Müller-Tidow, Carsten; Dreger, Peter; Schmitt, Michael.
Afiliação
  • Schubert ML; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Schmitt A; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Hückelhoven-Krauss A; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Neuber B; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Kunz A; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Waldhoff P; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Vonficht D; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
  • Yousefian S; Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.
  • Jopp-Saile L; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
  • Wang L; Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Korell F; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
  • Keib A; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany.
  • Michels B; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
  • Haas D; Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.
  • Sauer T; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
  • Derigs P; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Kulozik A; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Kunz J; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Pavel P; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Laier S; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Wuchter P; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Schmier J; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Bug G; Department of Pediatric Hematology, Oncology and Immunology, University Hospital Heidelberg, Heidelberg, Germany.
  • Lang F; Department of Pediatric Hematology, Oncology and Immunology, University Hospital Heidelberg, Heidelberg, Germany.
  • Gökbuget N; Institute for Clinical Transfusion Medicine and Cell Therapy (IKTZ), German Red Cross Blood Service Baden-Württemberg-Hessen, Heidelberg, Germany.
  • Casper J; Institute for Clinical Transfusion Medicine and Cell Therapy (IKTZ), German Red Cross Blood Service Baden-Württemberg-Hessen, Heidelberg, Germany.
  • Görner M; Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, of the Heidelberg University, German Red Cross Blood Service Baden-Württemberg - Hessen, Mannheim, Germany.
  • Finke J; GRN MVZ Sinsheim, Sinsheim, Germany.
  • Neubauer A; Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt, Germany.
  • Ringhoffer M; Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt, Germany.
  • Wolleschak D; Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt, Germany.
  • Brüggemann M; Department of Hematology and Oncology, University Hospital Oldenburg, Oldenburg, Germany.
  • Haas S; Department of Hematology and Oncology, Hospital Bielefeld, Bielefeld, Germany.
  • Ho AD; Department of Internal Medicine I, University Hospital Freiburg, Freiburg, Germany.
  • Müller-Tidow C; Department of Hematology, Oncology and Immunology, University Hospital Giessen und Marburg, Marburg, Germany.
  • Dreger P; Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.
  • Schmitt M; Department of Hematology and Oncology, Center of Internal Medicine, Otto-von-Guericke University Medical Center, Magdeburg, Germany.
J Hematol Oncol ; 16(1): 79, 2023 07 22.
Article em En | MEDLINE | ID: mdl-37481608
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Neurotóxicas Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Neurotóxicas Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article